OWA
DGX icon

One Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

One Wealth Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$298K Buy
1,407
+19
+1% +$3.73K 0.03% 266
2026
Q1 		$272K Hold
1,388
– – 0.03% 256
2025
Q4 		$241K Hold
1,388
– – 0.03% 268
2025
Q3 		$265K Buy
1,388
+188
+16% +$33.4K 0.03% 254
2025
Q2 		$216K Buy
+1,200
New +$208K 0.03% 270
2023
Q1 		– Sell
-1,597
Closed -$250K – 301
2022
Q4 		$250K Sell
1,597
-833
-34% -$120K 0.06% 162
2022
Q3 		$298K Buy
2,430
+486
+25% +$64K 0.1% 117
2022
Q2 		$259K Buy
1,944
+61
+3% +$8.31K 0.07% 152
2022
Q1 		$258K Buy
1,883
+304
+19% +$42.4K 0.06% 171
2021
Q4 		$273K Buy
+1,579
New +$240K 0.07% 147
2019
Q2 		– Sell
-50
Closed -$4K – 206
2019
Q1 		$4K Buy
+50
New +$4.33K ﹤0.01% 381
2018
Q2 		– Sell
-2,155
Closed -$224K – 562
2018
Q1 		$216K Buy
2,155
+104
+5% +$10.7K 0.19% 106
2017
Q4 		$202K Buy
+2,051
New +$194K 0.16% 107

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

One Wealth Advisors's DGX Position: Q2 2026 in Review

One Wealth Advisors increased its Quest Diagnostics (DGX) stake by 1.4% in Q2 2026, buying an estimated $3.73K and bringing the position to 1,407 shares worth $298K. The position accounts for 0.03% of the portfolio, ranked #266.

One Wealth Advisors first reported a position in DGX in Q4 2017 and has held it in 13 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • One Wealth Advisors held 1,407 shares of Quest Diagnostics worth $298K as of Q2 2026.
  • One Wealth Advisors bought 19 Quest Diagnostics shares in Q2 2026, an estimated $3.73K.
  • Quest Diagnostics made up 0.03% of One Wealth Advisors's portfolio in Q2 2026, its #266 holding.
  • One Wealth Advisors first reported a position in Quest Diagnostics in Q4 2017 and has held it in 13 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on One Wealth Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.